"My view is that Management has no concept on how to articulate its achievements or have any skills in forging forward and laying the groundwork in building a company which will take the world by storm. They are the good backroom boys but lacking elements of business management."
Thanks for posting this, in particular the Management bit - it's a very challenging view and I have spent a long time considering the many components and connecting the dots to the following response posted by
@Moreforme
Considering most posters here are fixated on the search for partnerships (espoused by Silviu) this needs to be the main focus for sure. On management I'm fascinated by how cavalier the company is on running their cash down to rock bottom before switching on a placement or potentially the "facility". I want to find a place for the word "brinkmanship" here because that's what it smells like to my nose; they seem to be very confident about where they are going and whatever bum luck they might have on the road - it's like driving a steam tractor across the Australian continent and if the dry firewood store gets low, no worry just stop anywhere and cut a tree down! Wouldn't it be the case that a partner for CHF will require their funding monies to support CHF exclusively - not the whole steam tractor? Now MNK have an option to move for CHF development - and this strategy has a closing date. I suppose that means other parties cannot move on CHF and all it's extrapolations until that date (excluding of course what they might discuss in private with our CEO)
Under ASX rules MSB has to put on the record any information that could affect the company or the share price, yes? But the whole purpose of private club dining rooms is for directors to chat over cigars regarding "what might be" when the sun comes up tomorrow. So who is Silviu sharing cigars with? - we will never know unless he is ready - but I am tempted by the thought he is very confident about the hand he is holding as per
@Moreforme
It frustrates the hell out of me that I cannot "see" where this is likely going - not being a scientist I don't care for the minutiae of trial interpretation. Just the human and market behavior for me. But I enjoyed these two posts, taken together.
How many other candidates are out there, lying low? Before FDA approvals are even granted what potential price do they put on their entry into the family?---ongoing funding contribution to final development - plus new placement at VWAP minus X - $1.00 to $1.50?? Who would have a clue but you'd better have a high tolerance for cigar smoke if you want to find out!
Then there's the share price spikes - please tell us if you know anyone who knows anyone who knows what's going on there? We have had a lot of fun trashing the short selling "industry" here and boy don't they deserve it - still a bottomless black hole of opportunity for cheaters. But do I blame them for two price events running up to $3.00+.......definitely not! Did a few shorters get burned ...maybe. Just my opinion but the scenarios described points to insider trading based on hot rumors in the secret passages of US biotech/analyst/bank flunkie land: eg Silviu went to London for three days, BOD having un-scheduled meetings off site all departed wearing sunglasses, stock lenders calling back any MSB scrip, Chinese visitors in the MSB car park, analyst on the juice bragging about a big event.
Have fun with that, it could be as simple as MNK gearing up for a partnership. But we have been talking about partnerships for years and still nothing.............
It would pave a way for CHF in the long term post FDA, but does nothing for RA or LBP?
What then, more placements, draw downs? More erratic share price all over again? I'm not up for that.
I am up for complete takeover for one big ticket therapy but if not I hope
@Moreforme is right.
(20min delay)